Skip to main content

Efficacy of a nurse-facilitated mindfulness-based management program on severity of childhood cancer symptom cluster-leukemia in adolescents with leukemia receiving chemotherapy: A multicenter randomized controlled trial

In brief

Mindfulness program lowers leukemia symptom scores by 1.63 at eight weeks

In a randomized trial of 60 adolescents receiving induction chemotherapy, a four-week nurse-facilitated mindfulness program was associated with symptom-cluster severity scores 1.63 lower than usual care at eight weeks. The intervention group also reported higher quality of life at week 12, but the small trial in three Thai hospitals leaves its value in other settings uncertain.

Journal
European journal of oncology nursing : the official journal of European Oncology Nursing Society (Q1)
Published
17 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Wannita Sonkongdang, Jutarat Mesukko, Srimana Niyomkar, Petsunee Thungjaroenkul
PMID
43056787
DOI
10.1016/j.ejon.2026.103364

Why clinicians should know about it

  • Picked for Hematology (top studies of the week, 22 November 2026): Randomized trial of symptom management during adolescent leukemia chemotherapy

Abstract

PURPOSE: This study evaluated the efficacy of a mindfulness-based symptom cluster management program on CCSC-L severity and HRQoL. METHODS: A two-arm multicenter randomized controlled trial with repeated outcome measurements was conducted among 60 adolescents receiving induction chemotherapy at three tertiary hospitals in Thailand. Participants were stratified by hospital and randomly assigned (1:1) to receive either the program based on the Individual and Family Self-Management Theory plus usual care or usual care alone. The symptom cluster severity was assessed immediately after completion of the four-week structured intervention and at Weeks 4 and 8, and HRQoL at Week 12. Linear mixed-effects models and between-group comparisons were performed. RESULTS: Linear mixed-effects modeling demonstrated a significant group × time interaction for overall symptom cluster severity (p < .001). Compared with usual care, adolescents receiving the intervention demonstrated significantly lower overall symptom cluster severity at Week 4 (model-estimated mean difference = -0.90) and Week 8 (model-estimated mean difference = -1.63). Significant between-group differences favoring the intervention were observed across all five symptoms at both assessments (all unadjusted p ≤ .001). At Week 12, the complete-case analysis (intervention, n = 30; control, n = 28) showed higher overall HRQoL in the intervention group (mean difference = 11.59, 95% CI [8.56,14.62], unadjusted p < .001). CONCLUSIONS: The program reduced symptom cluster severity and improved HRQoL. These findings suggest that the intervention could be considered for integration into routine pediatric oncology nursing practice in similar clinical settings. TRIAL REGISTRATION: Thai Clinical Trials Registry (TCTR20250608004); prospectively registered on 8 June 2025, before the first participant was enrolled on 20 June 2025.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.